Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 1 2

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Urinary Bladder Neoplasms 18Non-Muscle Invasive Bladder Neoplasms 12Carcinoma, Transitional Cell 11Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Anus Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma 3Urologic Neoplasms 2Urologic Diseases 2Urogenital Neoplasms 2Urinary Bladder Diseases 2Stomach Neoplasms 2Neoplasms by Site 2Colonic Neoplasms 2Anal Canal Carcinoma 2Uterine Cervical Neoplasms 1Urogenital Diseases 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mycobacterium Infections 1

Interventions

Sorafenib 42lenvatinib 21Fluorouracil 16atezolizumab 15Oxaliplatin 14Bevacizumab 13Doxorubicin 12Radiosurgery 11Leucovorin 11Radiofrequency Ablation 10Ethiodized Oil 10pembrolizumab 7Folfox protocol 7sintilimab 6durvalumab 6Radiotherapy 6Nivolumab 6Epirubicin 6Cisplatin 6tremelimumab 5Gemcitabine 5apatinib 4Embolization, Therapeutic 4tislelizumab 3camrelizumab 3cabozantinib 3Tenofovir 3Pharmaceutical Preparations 3Mitomycin 3Magnetic Resonance Spectroscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Hepatocellular × Mitomycin × Clear all
NCT01004978 2024-01-03

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
235 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01327521 2012-06-11

Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

Stanford University

Phase 3 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡